KB105 / Krystal Biotech 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
KB105 / Krystal Biotech
NCT05735158: Topical KB105 for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI)

Not yet recruiting
2
15
US
KB105, Placebo
Krystal Biotech, Inc.
Autosomal Recessive Ichthyosis
03/24
04/24
NCT04047732: Topical KB105 Gene Therapy for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI)

Active, not recruiting
1/2
6
US
KB105, HSV1-TGM1
Krystal Biotech, Inc.
TGM-1 Related Autosomal Recessive Congenital Ichthyosis
10/22
03/25

Download Options